Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1989 1
1990 2
1992 1
1994 2
1996 3
1997 2
1998 5
1999 2
2000 2
2001 4
2002 5
2003 4
2004 8
2005 8
2006 10
2007 9
2008 14
2009 12
2010 14
2011 25
2012 27
2013 21
2014 15
2015 20
2016 20
2017 14
2018 25
2019 18
2020 28
2021 26
2022 30
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

302 results
Results by year
Filters applied: . Clear all
Page 1
Recommendations for cognitive screening and management in multiple sclerosis care.
Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, Gingold J, Goverover Y, Halper J, Harris C, Kostich L, Krupp L, Lathi E, LaRocca N, Thrower B, DeLuca J. Kalb R, et al. Among authors: benedict rh. Mult Scler. 2018 Nov;24(13):1665-1680. doi: 10.1177/1352458518803785. Epub 2018 Oct 10. Mult Scler. 2018. PMID: 30303036 Free PMC article. Review.
Epidemiology and treatment of multiple sclerosis in elderly populations.
Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R, Weinstock-Guttman B. Vaughn CB, et al. Among authors: benedict rhb. Nat Rev Neurol. 2019 Jun;15(6):329-342. doi: 10.1038/s41582-019-0183-3. Nat Rev Neurol. 2019. PMID: 31000816 Review.
Cognition in multiple sclerosis: Charcot was right.
Benedict RHB. Benedict RHB. Lancet Neurol. 2020 Oct;19(10):810. doi: 10.1016/S1474-4422(20)30306-9. Epub 2020 Sep 16. Lancet Neurol. 2020. PMID: 32949540 Review. No abstract available.
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years.
Cree BA, Arnold DL, Fox RJ, Gold R, Vermersch P, Benedict RH, Bar-Or A, Piani-Meier D, Rouyrre N, Ritter S, Kilaru A, Karlsson G, Giovannoni G, Kappos L. Cree BA, et al. Among authors: benedict rh. Mult Scler. 2022 Sep;28(10):1591-1605. doi: 10.1177/13524585221083194. Epub 2022 Apr 5. Mult Scler. 2022. PMID: 35380078 Free PMC article.
Multiple sclerosis.
Benedict RH, Bobholz JH. Benedict RH, et al. Semin Neurol. 2007 Feb;27(1):78-85. doi: 10.1055/s-2006-956758. Semin Neurol. 2007. PMID: 17226744 Review.
Aging and multiple sclerosis.
Sanai SA, Saini V, Benedict RH, Zivadinov R, Teter BE, Ramanathan M, Weinstock-Guttman B. Sanai SA, et al. Among authors: benedict rh. Mult Scler. 2016 May;22(6):717-25. doi: 10.1177/1352458516634871. Epub 2016 Feb 19. Mult Scler. 2016. PMID: 26895718 Review.
Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study.
Gold R, Piani-Meier D, Kappos L, Bar-Or A, Vermersch P, Giovannoni G, Fox RJ, Arnold DL, Benedict RHB, Penner IK, Rouyrre N, Kilaru A, Karlsson G, Ritter S, Dahlke F, Hach T, Cree BAC. Gold R, et al. Among authors: benedict rhb. J Neurol. 2022 Sep;269(9):5093-5104. doi: 10.1007/s00415-022-11166-z. Epub 2022 May 31. J Neurol. 2022. PMID: 35639197 Free PMC article. Clinical Trial.
302 results